Generated by GPT-5-mini| bacteriophage λ | |
|---|---|
| Name | bacteriophage lambda |
| Family | Siphoviridae |
| Genus | Lambdavirus |
| Species | Enterobacteria phage lambda |
| Genome | dsDNA (~48.5 kb) |
| Hosts | Escherichia coli |
| Discovery | 1950s |
bacteriophage λ
Bacteriophage λ is a temperate double-stranded DNA virus infecting Escherichia coli and related Enterobacteriaceae. It played a central role in mid-20th century molecular biology research at institutions such as the University of California, Berkeley, the Cold Spring Harbor Laboratory, and the MRC Laboratory of Molecular Biology. Studies of λ informed work by scientists affiliated with the Max Planck Society, the Pasteur Institute, and laboratories influenced by recipients of the Nobel Prize in Physiology or Medicine.
λ was discovered in the context of viral studies of Escherichia coli during the 1950s at centers like University of Glasgow and research groups involving members linked to the Royal Society and the National Institutes of Health. Early investigators whose careers intersected with λ included scientists associated with the California Institute of Technology, the University of Chicago, and the Carnegie Institution for Science. The phage became instrumental in experiments contemporaneous with work by scholars from the Institut Pasteur and laboratories influenced by the Rockefeller University, contributing to paradigms later discussed in reviews from the American Society for Microbiology.
The λ virion exhibits a non-enveloped morphology typical of the Siphoviridae family, with a capsid and a long flexible tail whose structural determinants were elucidated in collaborations across the European Molecular Biology Laboratory and the Weizmann Institute of Science. Its linear double-stranded DNA genome (~48.5 kilobase pairs) encodes regulatory circuits and structural proteins studied by groups at the Johns Hopkins University, University of California, San Francisco, and the Massachusetts Institute of Technology. Genome ends and cohesive sites (cos) were characterized in work tied to techniques developed at the Cold Spring Harbor Laboratory and the Max Planck Institute for Molecular Genetics. High-resolution structural biology of λ components has been pursued with instrumentation from facilities such as the Advanced Photon Source and centers linked to the European Synchrotron Radiation Facility.
λ displays a choice between lytic and lysogenic pathways, a decision mediated by gene regulatory networks analyzed by researchers at the Princeton University, the Stanford University, and the University of Cambridge. The central regulatory proteins and promoters regulating this switch were mapped in studies associated with labs from the Salk Institute, the Harvard University, and the University of Illinois Urbana-Champaign. Operators, promoters, and transcriptional regulators in λ were central to experiments performed by scientists connected to the American Association for the Advancement of Science and investigators influenced by laureates of the Lasker Award. Models of bistability and switch behavior involving stochastic gene expression were developed in theoretical collaborations involving the Institute for Advanced Study and the Santa Fe Institute.
λ served as a foundational genetic system in experiments alongside models used at the Max Planck Institute for Biophysical Chemistry and the European Molecular Biology Organization. Recombination, DNA replication, and site-specific recombination mechanisms discovered in λ informed broader genetic frameworks explored by teams at the University of Oxford, the Yale University, and the University of Toronto. λ-based vectors and genetic tools influenced work at the Broad Institute, the Wellcome Trust Sanger Institute, and biotechnology companies originating from Cambridge, Massachusetts and San Francisco. Techniques such as in vitro packaging, genetic mapping, and mutational analysis were refined in methods courses at the Cold Spring Harbor Laboratory and workshops supported by the Howard Hughes Medical Institute.
λ derivatives and components have been applied in molecular cloning, phage display adaptations, and synthetic biology projects developed at the MIT Media Lab, the Wyss Institute for Biologically Inspired Engineering, and industrial labs tied to the Biotechnology Innovation Organization. Phage therapy research and microbiome modulation efforts referencing λ biology have been reported from clinical research centers affiliated with the Mayo Clinic, the Cleveland Clinic, and the National Institute of Allergy and Infectious Diseases. Structural and genomic insights from λ have informed projects funded by agencies such as the European Research Council, the National Science Foundation, and the Wellcome Trust.
λ-host interactions involve adsorption, DNA injection, and host control mechanisms studied in contexts involving bacterial strains curated by culture collections like the American Type Culture Collection and consortia linked to the European Nucleotide Archive. Host factors, restriction-modification systems, and CRISPR-related defenses that affect λ dynamics were characterized in laboratories at the University of California, San Diego, the ETH Zurich, and the University of Copenhagen. The ecological and evolutionary implications of λ infections have been analyzed in collaborative programs involving the Smithsonian Institution, the Natural History Museum, London, and environmental microbiology groups associated with the United States Geological Survey.
Category:Bacteriophages